These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 18385451)

  • 1. The reactivity of Bw4+ HLA-B and HLA-A alleles with KIR3DL1: implications for patient and donor suitability for haploidentical stem cell transplantations.
    Foley BA; De Santis D; Van Beelen E; Lathbury LJ; Christiansen FT; Witt CS
    Blood; 2008 Jul; 112(2):435-43. PubMed ID: 18385451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematopoietic stem cell transplantation: Improving alloreactive Bw4 donor selection by genotyping codon 86 of KIR3DL1/S1.
    Alicata C; Pende D; Meazza R; Canevali P; Loiacono F; Bertaina A; Locatelli F; Nemat-Gorgani N; Guethlein LA; Parham P; Moretta L; Moretta A; Bottino C; Norman PJ; Falco M
    Eur J Immunol; 2016 Jun; 46(6):1511-7. PubMed ID: 26990677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human leukocyte antigens A23, A24, and A32 but not A25 are ligands for KIR3DL1.
    Stern M; Ruggeri L; Capanni M; Mancusi A; Velardi A
    Blood; 2008 Aug; 112(3):708-10. PubMed ID: 18502829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-A alleles influencing NK cell function impact AML relapse following allogeneic hematopoietic cell transplantation.
    van der Ploeg K; Le Luduec JB; Stevenson PA; Park S; Gooley TA; Petersdorf EW; Shaffer BC; Hsu KC
    Blood Adv; 2020 Oct; 4(19):4955-4964. PubMed ID: 33049053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor KIR3DL1/3DS1 gene and recipient Bw4 KIR ligand as prognostic markers for outcome in unrelated hematopoietic stem cell transplantation.
    Gagne K; Busson M; Bignon JD; Balère-Appert ML; Loiseau P; Dormoy A; Dubois V; Perrier P; Jollet I; Bois M; Masson D; Moine A; Absi L; Blaise D; Charron D; Raffoux C;
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1366-75. PubMed ID: 19822295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The impact of donor human leukocyte antigen-Bw4 allele on natural killer cell reconstitution and transplant-related mortality in haploidentical transplantation].
    Zhao M; Xu ZL; Yu XX; Ding YY; Chang YJ; Zhang XH; Liu KY; Huang XJ; Zhao XY
    Zhonghua Xue Ye Xue Za Zhi; 2024 May; 45(5):453-461. PubMed ID: 38964919
    [No Abstract]   [Full Text] [Related]  

  • 7. KIR3DL1/HLA-B Subtypes Govern Acute Myelogenous Leukemia Relapse After Hematopoietic Cell Transplantation.
    Boudreau JE; Giglio F; Gooley TA; Stevenson PA; Le Luduec JB; Shaffer BC; Rajalingam R; Hou L; Hurley CK; Noreen H; Reed EF; Yu N; Vierra-Green C; Haagenson M; Malkki M; Petersdorf EW; Spellman S; Hsu KC
    J Clin Oncol; 2017 Jul; 35(20):2268-2278. PubMed ID: 28520526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor.
    Gumperz JE; Litwin V; Phillips JH; Lanier LL; Parham P
    J Exp Med; 1995 Mar; 181(3):1133-44. PubMed ID: 7532677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional polymorphism of the KIR3DL1/S1 receptor on human NK cells.
    O'Connor GM; Guinan KJ; Cunningham RT; Middleton D; Parham P; Gardiner CM
    J Immunol; 2007 Jan; 178(1):235-41. PubMed ID: 17182560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KIR3DL1 and HLA-B Density and Binding Calibrate NK Education and Response to HIV.
    Boudreau JE; Mulrooney TJ; Le Luduec JB; Barker E; Hsu KC
    J Immunol; 2016 Apr; 196(8):3398-410. PubMed ID: 26962229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-Bw4 80(T) and multiple HLA-Bw4 copies combined with KIR3DL1 associate with spontaneous clearance of HCV infection in people who inject drugs.
    Thöns C; Senff T; Hydes TJ; Manser AR; Heinemann FM; Heinold A; Heilmann M; Kim AY; Uhrberg M; Scherbaum N; Lauer GM; Khakoo SI; Timm J
    J Hepatol; 2017 Sep; 67(3):462-470. PubMed ID: 28412292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation.
    Ruggeri L; Capanni M; Casucci M; Volpi I; Tosti A; Perruccio K; Urbani E; Negrin RS; Martelli MF; Velardi A
    Blood; 1999 Jul; 94(1):333-9. PubMed ID: 10381530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutting Edge: Allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B.
    Thananchai H; Gillespie G; Martin MP; Bashirova A; Yawata N; Yawata M; Easterbrook P; McVicar DW; Maenaka K; Parham P; Carrington M; Dong T; Rowland-Jones S
    J Immunol; 2007 Jan; 178(1):33-7. PubMed ID: 17182537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KIR and their HLA Class I ligands: Two more pieces towards completing the puzzle of chronic rejection and graft loss in kidney transplantation.
    Littera R; Piredda G; Argiolas D; Lai S; Congeddu E; Ragatzu P; Melis M; Carta E; Michittu MB; Valentini D; Cappai L; Porcella R; Alba F; Serra M; Loi V; Maddi R; Orrù S; La Nasa G; Caocci G; Cusano R; Arras M; Frongia M; Pani A; Carcassi C
    PLoS One; 2017; 12(7):e0180831. PubMed ID: 28686681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoinformatic docking approach for the analysis of KIR3DL1/HLA-B interaction.
    Grifoni A; Montesano C; Patronov A; Colizzi V; Amicosante M
    Biomed Res Int; 2013; 2013():283805. PubMed ID: 23984333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV infection abrogates the functional advantage of natural killer cells educated through KIR3DL1/HLA-Bw4 interactions to mediate anti-HIV antibody-dependent cellular cytotoxicity.
    Parsons MS; Wren L; Isitman G; Navis M; Stratov I; Bernard NF; Kent SJ
    J Virol; 2012 Apr; 86(8):4488-95. PubMed ID: 22345455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interaction of KIR3DL1*001 with HLA class I molecules is dependent upon molecular microarchitecture within the Bw4 epitope.
    Saunders PM; Vivian JP; Baschuk N; Beddoe T; Widjaja J; O'Connor GM; Hitchen C; Pymm P; Andrews DM; Gras S; McVicar DW; Rossjohn J; Brooks AG
    J Immunol; 2015 Jan; 194(2):781-789. PubMed ID: 25480565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA alleles determine differences in human natural killer cell responsiveness and potency.
    Kim S; Sunwoo JB; Yang L; Choi T; Song YJ; French AR; Vlahiotis A; Piccirillo JF; Cella M; Colonna M; Mohanakumar T; Hsu KC; Dupont B; Yokoyama WM
    Proc Natl Acad Sci U S A; 2008 Feb; 105(8):3053-8. PubMed ID: 18287063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Killer cell immunoglobulin-like receptor 3DL1 licenses CD16-mediated effector functions of natural killer cells.
    Parsons MS; Zipperlen K; Gallant M; Grant M
    J Leukoc Biol; 2010 Nov; 88(5):905-12. PubMed ID: 20664023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KIR3DL1 Allelic Polymorphism and HLA-B Epitopes Modulate Response to Anti-GD2 Monoclonal Antibody in Patients With Neuroblastoma.
    Forlenza CJ; Boudreau JE; Zheng J; Le Luduec JB; Chamberlain E; Heller G; Cheung NK; Hsu KC
    J Clin Oncol; 2016 Jul; 34(21):2443-51. PubMed ID: 27069083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.